Microdosing and human drug absorption studies under the spotlight in live web seminar set for 4 November 2004
Strategies to improve decision-making in early drug development will be under the spotlight on 4 November 2004 when one of the industry's leading early phase specialists hosts a web-based discussion and presentation.
The on-line sessions have been designed by Pharmaceutical Profiles (Nottingham, UK) to provide an informative and thought-provoking overview to help highlight the key challenges facing the pharmaceutical industry and examine innovative solutions to typical problems.
It is the company's second major 'webinar'.
The first was attended on-line by more than 60 key industry delegates and was delivered by Professor Ian Wilding, a frequent speaker at international meetings and a respected authority on drug delivery and intestinal absorption.
He will also deliver the second webinar.
The presentation will include an overview of the current drug development process and whether it is in need of real innovation, Phase 0 PK/Adme studies and the benefits of utilising microdosing technologies, employing microdosing investigations to increase productivity in early drug development, human drug absorption studies as a 'route map' for product development and choosing the correct enabling technologies using human drug absorption investigations.
